Nextcure to present at the 35th annual piper sandler healthcare conference

Beltsville, md., nov. 20, 2023 (globe newswire) -- nextcure, inc. (nasdaq: nxtc), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases, today announced that it will participate in a fireside chat at the 35th annual piper sandler healthcare conference in new york city on thursday, november 30th, at 1:30 pm et.
NXTC Ratings Summary
NXTC Quant Ranking